Skip to main content
letter
. 2018 Jun 2;52(3):501–503. doi: 10.1016/j.jmii.2018.04.005

Table 1.

A summary of pregnancy associated MERS-CoV infection.

Age Nationality Gravida (G), Para (P) Source of infection Gestational age at illness onset (weeks) ICU admission Maternal comorbid conditions Maternal outcome Fetal outcome Delivery details Reference
Patient 1 (PMAH) 29 Saudi G2, P1 Household contact 6 NO None Survived Survived Delivery at term Current report
Patient 2 (PMAH) 39 Saudi G6, P5 Contact with MERS-CoV case in HD 24 NO ESRD on hemodialysis, HTN Survived Survived Delivery at term Current report
Patient 3 34 Saudi G7, P6 Unknown 34 YES Preeclampsia Survived Died Intrauterine Fetal death at 34 weeks 3
Patient 4 32 Saudi G2, P1 Unknown 38 YES None Died Survived Vaginal delivery at 38 weeks 3
Patient 5 31 Saudi Primigravida HCW, occupational exposure 24 YES Asthma, pulmonary fibrosis Died Died Caesarean section at 24 weeks 3
Patient 6 27 Saudi Primigravida Unknown 22 YES None Survived Survived Full term delivery 3
Patient 7 30 Saudi Primigravida HCW, occupational exposure 23 YES None Survived Survived Full term delivery 3
Patient 8 39 Jordanian G7, P6 Household contact 20 NO None Survived Still birth Still birth at 5 months 6
Patient 9 32 United Arab Emirates G3, P2 Visited camel barn 32 YES None Died Survived Caesarean section at 32 weeks 5
Patient 10 39 South Korean G2, P1 Contact with MERS-CoV Patient in hospital 35 weeks and 4 days NO Gestational Diabetes Survived Survived Caesarean section at 39 weeks 2, 7
Patient 11 33 Saudi Primigravida Contact with MERS-CoV Patient 31 Yes Hypothyroidism and primary infertility Survived Survived Caesarean section at 32 weeks 4